CD28 Antibody (AP-MAB0818) Summary
mouse T-cell lymphoma
The was selected for its ability to detect Thymocytes, CD4+, CD8+ peripheral T cells, NK cells
IgG
Monoclonal
Golden Syrian Hamster
CD28
Protein A or G purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Blocking/Neutralizing 50-200 molar excess
Costimulation of T and NK cells (in vivo), Blocking of allogeneic mixed leukocyte response and inhibition of MHC unrestricted CTL cytotoxicity and Induction of thymocyte differentiation
Reactivity Notes
Mouse.
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
A 0.2 um filtered solution in PBS – Azide free
No Preservative
1.0 mg/ml
Protein A or G purified
Alternate Names for CD28 Antibody (AP-MAB0818)
- CD28 antigen (Tp44)
- CD28 antigen
- CD28 molecule
- CD28
- MGC138290
- T-cell-specific surface glycoprotein CD28
- Tp44
Background
CD28 antigen is a 44 kDa disulfide linked homodimeric T cell specific surface glycoprotein. It is a cell adhesion molecule of the immunoglobulin superfamily which is constitutively expressed on most peripheral blood T lymphocytes (approximately 95% of CD4+ cells and 50% of CD8+ cells). Mature thymocytes exhibit higher levels of CD28 than the immature cells. Activation of T cells results in enhanced CD28 expression. T cell activation requires two combined signals provided by antigen presenting cells. The first is mediated via the T cell receptor following its interaction with antigenic peptide MHC complexes, and the second is delivered by accessory or costimulating molecules through their counter receptors on T lymphocytes. CD28 bears structural homology to CTLA 4 which is expressed at very low levels on the surface of CD4+ and CD8+ peripheral blood cells only following activation. CD28 is the natural receptor for the B7/BB 1 ligand (CD80) a 55-60 kDa glycoprotein which is expressed on activated B lymphocytes, on dendritic cells and on interferon gamma treated monocytes. The binding of B7 1/BB 1 molecules to CD28 is involved in T lymphocyte activation and in the initiation and maintenance of chronic inflammation.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.